Literature DB >> 20972455

The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.

J J Qiu1, H Chu, X Lu, X Jiang, S Dong.   

Abstract

The paired box domain of PAX5 was reported to fuse with the sequence of promyelocytic leukemia (PML) to produce PAX5-PML chimeric protein in two patients with B-cell acute lymphoblastic leukemia. In the present studies, we found, by gel shift assays, that PAX5-PML bound to a panel of PAX5-consensus sequence acts as a homodimer with reduction of its DNA-binding affinities in comparison with wild-type PAX5. In transient transfection assays using 293T and HeLa cells, and retrovirus transduction of murine hematopoietic stem/progenitor cells together with quantitative real-time polymerase chain reaction analysis, PAX5-PML inhibited wild-type PAX5 target gene transcriptional activity. Studies comparing PAX5-PML with PAX5-PML(ΔCC) demonstrated that the coiled-coil (CC) protein interaction domain located within the PML moiety was required for PAX5-PML homodimer complex formation and partial transcriptional repression of genes controlled by PAX5. Fluorescent microscopic examination of transiently expressed YFP-tagged proteins in HeLa and 293T cells demonstrated that YFP-PAX5-PML and YFP-PAX5-PML(ΔCC) exhibited a diffuse granular pattern within the nucleus, similar to PAX5 but not PML. By fluorescent recovery after photobleach (FRAP), we have shown that PAX5-PML fusion protein has reduced intranuclear mobility compared with wild-type PAX5. Furthermore, the dimerization domain (CC) of PML was responsible for the reduced intranuclear mobility of PAX5-PML. These results indicate that the CC domain of PAX5-PML is important for each of the known activities of PAX5-PML fusion proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972455     DOI: 10.1038/onc.2010.473

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Anopheles Midgut FREP1 Mediates Plasmodium Invasion.

Authors:  Genwei Zhang; Guodong Niu; Caio M Franca; Yuemei Dong; Xiaohong Wang; Noah S Butler; George Dimopoulos; Jun Li
Journal:  J Biol Chem       Date:  2015-05-19       Impact factor: 5.157

Review 2.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

3.  Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.

Authors:  Leonie Smeenk; Maria Fischer; Sabine Jurado; Markus Jaritz; Anna Azaryan; Barbara Werner; Mareike Roth; Johannes Zuber; Martin Stanulla; Monique L den Boer; Charles G Mullighan; Sabine Strehl; Meinrad Busslinger
Journal:  EMBO J       Date:  2017-02-20       Impact factor: 11.598

4.  The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Klaus Fortschegger; Maximilian Kauer; João R M Marchante; Reinhard Kofler; Monique L Den Boer; Sabine Strehl
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113

5.  Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.

Authors:  J J Qiu; B B Zeisig; S Li; W Liu; H Chu; Y Song; A Giordano; J Schwaller; H Gronemeyer; S Dong; C W E So
Journal:  Leukemia       Date:  2014-12-16       Impact factor: 11.528

6.  B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.

Authors:  Naoto Imoto; Fumihiko Hayakawa; Shingo Kurahashi; Takanobu Morishita; Yuki Kojima; Takahiko Yasuda; Keiki Sugimoto; Shinobu Tsuzuki; Tomoki Naoe; Hitoshi Kiyoi
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

7.  Dominant-negative mechanism of leukemogenic PAX5 fusions.

Authors:  N Kawamata; M A Pennella; J L Woo; A J Berk; H P Koeffler
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

8.  A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.

Authors:  Xueqing Jiang; Lin Sun; Jihui Julia Qiu; Xiujing Sun; Sen Li; Xiyin Wang; Chi Wai Eric So; Shuo Dong
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

9.  FBN30 in wild Anopheles gambiae functions as a pathogen recognition molecule against clinically circulating Plasmodium falciparum in malaria endemic areas in Kenya.

Authors:  Guodong Niu; Genwei Zhang; Caio Franca; Yingjun Cui; Stephen Munga; Yaw Afrane; Jun Li
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

10.  Oncogenic features of PHF8 histone demethylase in esophageal squamous cell carcinoma.

Authors:  Xiujing Sun; Jihui Julia Qiu; Shengtao Zhu; Bangwei Cao; Lin Sun; Sen Li; Peng Li; Shutian Zhang; Shuo Dong
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.